No heterogeneity was found by breast cancer subtypes, except for IL-13 (Phomogeneity = 0.04; Additional file 1: Table S3) suggesting a significant positive association with breast cancer risk limited to the ER+PR±HER2+ subtype. This evidence concerns the gene ESR1 and breast cancer.